Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010

40
Social media: Developing a strategy for pharma Daniel Ghinn Director of Digital Engagement Creation Healthcare

description

Slides from Daniel Ghinn's presentation at DIA (Drug Information Association) 4th Annual Clinical Forum, Lisbon, 13 October 2010. This session was part of the Medical Information & Communications track, and was aimed at orientating medical information professionals to the role of social media in healthcare engagement. It's a basic introduction to the changing roles of healthcare stakeholders and especially the 'e-Patient'; and includes examples of social media's role in healthcare engagement including a brand new case study of Pfizer's 'Can you feel my pain' strategy in Europe.

Transcript of Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010

Page 1: Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010

Social media: Developing a strategy for pharma

Daniel GhinnDirector of Digital EngagementCreation Healthcare

Page 2: Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010

The views and opinions expressed in the following PowerPoint slides are those of the individual presenter and should not be attributed to Drug Information Association, Inc. (“DIA”), its directors, officers, employees, volunteers, members, chapters, councils, Special Interest Area Communities or affiliates, or any organization with which the presenter is employed or affiliated.

 

These PowerPoint slides are the intellectual property of the individual presenter and are protected under the copyright laws of the United States of America and other countries. Used by permission. All rights reserved. Drug Information Association, DIA and DIA logo are registered trademarks or trademarks of Drug Information Association Inc. All other trademarks are the property of their respective owners.

Disclaimer

Drug Information Association www.diahome.org 2

Page 3: Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010

Insurer

Patient

Doctor

Specialist

Media

Hospital

Pharmaceutical company

The InternetThe Internet

Page 4: Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010

Motivations to go online

n= 32,000; Adults 16-64SOURCE: Breslauer, B. & Smith, T., October 2009. “Social media trends around the world! – The GlobalWeb Index (GWI)”

Page 5: Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010

% e-Patients by country

Sample size: 5,183• US: 1,000• UK: 1,078• Germany: 1,000• Russia: 1,081• China: 1,024

SOURCE: Health Influence in the Era of Public Engagement. Edelman, (January 2009)

Page 6: Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010

Searching for health information after diagnosis

Q: Right after you or a family member has been diagnosed with a condition or disease by a doctor, which of the following actions do you take right away?

Source: About.com Health Study (N = 1,321) June 2010

Page 7: Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010

Searching for health information about chronic conditions

Q: Six months after you or a family member has been diagnosed with a condition or disease by a doctor, which of the following actions do you take right away?

Source: About.com Health Study (N = 1,321) June 2010

Page 8: Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010

Challenges for pharma

Social media does not respect national or regulatory boundaries

Two-way engagement cannot be controlled like broadcast communications

Consumers do talk about adverse events via social media

The landscape continually changes

Page 9: Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010

‘Side effects’ mentions by therapy area

SOURCE: “Reportable Adverse Events and the Internet” Creation Healthcare, October 2010

% of potentially reportable adverse events amongst mentions,by therapy area studied, after adjusting for spam and anomalies

Of these, a minority would require further investigation as possible reportable adverse events

42%

14%

Page 10: Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010

Opportunities for pharma

Learn by measuring patient behaviour

Increase relevance of communications

Play a role as a stakeholder in public health

Respond to the rise of the e-patient

Page 11: Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010

Online discussions about Parkinson’s Disease

Loïc Elleboudt, UCB Pharma SA, Brussels, Belgium. Presented at the 2nd World Parkinson Congress, September 28-October 1, 2010; Glasgow, UK

Parkinson’s Disease symptom map by grouped theme found in online conversations amongst people with Parkinson’s and their carers

Page 12: Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010

The power of conversation

Johnson & Johnson

Health Channel on YouTube

Page 13: Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010

Overview: J&J Health Channel

Over 2.4 million views since 2008

Proactive engagement, interacting with comments: • Puts a human face on the corporation and

goes to core values of connecting with the customer, engaging and having 1-to-1 dialogue

90-95% videos are not product specific

Source of objective healthcare information

Page 14: Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010
Page 15: Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010

Approach

Engaging proactively

Honest and open stance on what is and isn’t within the control of the company - plain English legalities

Consistency in moderation of conversation;• Allowing controversial content, but drawing the

line on off-topic or inappropriate behavior

Just one part of J&J’s engagement strategy• Linked with Facebook; Twitter; Blogs

Page 16: Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010

In their words

Page 17: Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010

In their words

Page 18: Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010

Their advice

Page 19: Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010

Potential of patient community

TuDiabetes

patient community

Page 20: Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010

Overview

Page 21: Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010
Page 22: Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010
Page 23: Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010
Page 24: Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010

Observations

Page 25: Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010

How it started

Page 26: Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010

In their words

Page 27: Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010

Making Sense of Diabetes

Page 28: Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010

Making Sense of Diabetes

Page 29: Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010

Making Sense of Diabetes

Page 30: Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010

The strength of collaboration

Pfizer

Can You Feel My Pain?

Page 31: Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010

Concept: Can You Feel My Pain?

An awareness-raising and influencing campaign that exists online entirely in social media

Engaging through connectors (patient groups)

Multiple social media channels allow individuals to use preferred platforms

Page 32: Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010

International & multi-language

Europe-wide social media strategy embracing multiple languages

Regional strategy; local implementation

Channel-dependent approach to languages

Supports variations in local culture & channel preferences

Page 33: Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010

Facebook in multiple languages

Page 34: Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010

European e-petition

Page 35: Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010

Engagement via Twitter

Page 36: Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010

Cross-language communication through photography

Page 37: Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010

Engaging through partners

Patient groups equipped to use social media channels to support strategy

Flexible implementation options allow individual groups to support preferred channels

Collaborative awareness-raising adds value for each partner

Page 38: Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010

9 European patient groups equipped

Page 39: Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010

Key steps

Plan for engagement – it’s happening already

Seek out opportunities

Don’t ignore the challenges

Ask the difficult questions

Collaborate with colleagues

Research & discover what your customers & stakeholders are doing online

Page 40: Social Media & Pharma - DIA Clinical Forum, Lisbon 13 October 2010

Daniel GhinnDirector of Digital EngagementCreation Healthcare

[email protected]

http://creationhealthcare.comTwitter: @EngagementStrat